Regulatory nod given to conduct clinical trials of Colchicine: CSIR ...Middle East

Business Standard - Economy
Regulatory nod given to conduct clinical trials of Colchicine: CSIR
The Drugs Controller General of India (DCGI) has given approval to the CSIR and Laxai Life Sciences Private Limited to conduct clinical trial of Colchicine on COVID-19 patients, according to a statement on Saturday. Ram Vishwakarma, the advisor to the CSIR Director General, said Colchicine in combination with standard care will be an important therapeutic intervention for COVID-19 patients with cardiac co-morbidities and also for reducing pro-inflammatory cytokines, leading to faster recovery. A number of global studies have confirmed that cardiac complications during course of COVID-19 infections and post-Covid syndrome are leading to loss of many lives, and it is essential to look for new

Hence then, the article about regulatory nod given to conduct clinical trials of colchicine csir was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Regulatory nod given to conduct clinical trials of Colchicine: CSIR )

Apple Storegoogle play

Last updated :

Also on site :



Latest News